Verve Therapeutics
VERV
#7365
Rank
โ‚ฌ0.31 B
Marketcap
3,56ย โ‚ฌ
Share price
-6.41%
Change (1 day)
-70.07%
Change (1 year)

P/S ratio for Verve Therapeutics (VERV)

P/S ratio as of April 2025 (TTM): 11.2

According to Verve Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.7334. At the end of 2024 the company had a P/S ratio of 15.8.

P/S ratio history for Verve Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202415.8-83.47%
202395.3-84.47%
2022614
2021N/A